Soppinfeksjon, systemisk: Prognose
Systemiske soppinfeksjoner kan ha en usikker prognose. Mest avgjørende for utfallet er grunnsykdommen. Tidlig og riktig behandling av en systemisk soppinfeksjon gjør at de fleste overlever en slik infeksjon.
Annonse
Dette dokumentet er basert på det profesjonelle dokumentet Soppinfeksjon, systemisk . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Patterson TF. Advances and challenges in management of invasive mycoses. Lancet 2005; 366: 1013-25. PubMed
- von Lilienfeld-Toal M, Wagener J, Einsele H, et al. Invasive Fungal Infection. Dtsch Arztebl Int. 2019 Apr 19;116(16):271-278. PMID: 31159914;
- Pappas PG, Rex JH, Lee J et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003; 37: 634-43. PubMed
- Gudlaugsson O, Gillespie S, Lee K et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37: 1172-7. PubMed
- Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot JL and Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 2002; 21: 767-74. PubMed
- Ostrosky-Zeichner L. New approaches to the risk of Candida in the intensive care unit. Curr Opin Infect Dis 2003; 16: 533-7. PubMed
- Martin GS, Mannino DM, Eaton S and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54. New England Journal of Medicine
- Mora-Duarte J, Betts R, Rotstein C et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347: 2020-9. New England Journal of Medicine
- Eggiman P, Garbino J and Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702. PubMed
- Marty FM, Lee SJ, Fahey MM et al. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood 2003; 102: 2768-76. Blood
- Walsh TJ, Pappas P, Winston DJ et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225-34. New England Journal of Medicine
- Marr KA, Carter RA, Boeckh M, Martin P and Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358-66. Blood
- Helsedirektoratet. Antibiotika i sykehus. Nasjonal faglig retningslinje for bruk av antibiotika i sykehus. Sist oppdatert 08.01.2018. helsedirektoratet.no
- Pinel C, Fricker-Hidalgo H, Lebeau B et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003; 41: 2184-6. PubMed
- Helsedirektoratet. Antibiotika i sykehus. Sist faglig oppdatert 01. september 2020. www.helsedirektoratet.no